Literature DB >> 10233039

Roles of aldosterone and angiotensin in maturation of sodium appetite in furosemide-treated rats.

N E Rowland1, K R Morian.   

Abstract

When rats are treated with furosemide, there is a rapid natriuresis. However, increased sodium appetite does not occur until some time later. One hypothesis to explain this delay is that increased circulating levels of the hormones of sodium depletion prime or sensitize the brain circuits involved in sodium appetite, perhaps by induction of target gene(s). In the present study, we describe the time course of the temporal maturation of sodium appetite after furosemide treatment and the associated changes in plasma levels of ANG II and aldosterone and in plasma volume. Sodium appetite is modest 3 h after furosemide treatment, is increased after 12 h, and is still larger after 24 h. This pattern is evident with repeated testing. Plasma levels of aldosterone and plasma renin activity are substantially increased 3 h after furosemide treatment, and so the NaCl appetite cannot result simply from progressively increasing levels of these hormones. Furthermore, activation of the subfornical organ and the ventral lamina terminalis, assessed with c-Fos immunocytochemistry, did not differ across these three times. Metyrapone, an inhibitor of adrenal steroid synthesis, was used to examine sodium appetite in the absence of elevations in aldosterone after furosemide treatment. Although metyrapone effectively blocked the increase in aldosterone, it was without effect on the appetite 3 or 24 h after furosemide treatment. Furthermore, elevations of plasma aldosterone by the use of minipumps for several days before furosemide treatment did not prime or potentiate but instead tended to inhibit the induced sodium appetite, despite achieving levels of aldosterone and plasma renin activity typically associated with a robust sodium appetite. Infusions of DOCA gave a similar result. Lastly, minipump infusions of ANG II also did not potentiate sodium appetite. Thus neither addition nor subtraction of these hormones alone influenced sodium appetite under these conditions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233039     DOI: 10.1152/ajpregu.1999.276.5.R1453

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods.

Authors:  Ali Ahmed; Ahsan Husain; Thomas E Love; Giovanni Gambassi; Louis J Dell'Italia; Gary S Francis; Mihai Gheorghiade; Richard M Allman; Sreelatha Meleth; Robert C Bourge
Journal:  Eur Heart J       Date:  2006-05-18       Impact factor: 29.983

2.  Glucocorticoids increase salt appetite by promoting water and sodium excretion.

Authors:  Robert L Thunhorst; Terry G Beltz; Alan Kim Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-06-27       Impact factor: 3.619

3.  Variable effects of parabrachial nucleus lesions on salt appetite in rats depending upon experimental paradigm and saline concentration.

Authors:  Edward M Stricker; Patricia S Grigson; Ralph Norgren
Journal:  Behav Neurosci       Date:  2013-02-11       Impact factor: 1.912

4.  A propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure.

Authors:  Ali Ahmed; James B Young; Thomas E Love; Raynald Levesque; Betram Pitt
Journal:  Int J Cardiol       Date:  2007-08-16       Impact factor: 4.164

5.  Dysregulated Hypothalamic-Pituitary-Adrenal Axis Is Associated With Increased Inflammation and Worse Outcomes After Ischemic Stroke in Diabetic Mice.

Authors:  Sehee Kim; Eun S Park; Peng R Chen; Eunhee Kim
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

6.  Protocol for sodium depletion and measurement of sodium appetite in mice.

Authors:  Seahyung Park; Jong-Woo Sohn
Journal:  STAR Protoc       Date:  2021-12-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.